When it comes to 'breaking', 'late' and 'ground' should not be confused.
Wyllie
Mike G
MG
GlobalPharma Consulting Ltd, Sittingbourne Research Centre, Kent ME9 8PX, UK. m.wyllie@globalpharma.co.uk
D015195:Drug Design; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000191:economics / Q000627:therapeutic use; D011306:Prescription Fees; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy*
D010726:Phosphodiesterase Inhibitors